Literature DB >> 7728402

The occurrence, nature and distribution of flares in a cohort of patients with systemic lupus erythematosus: a rheumatological view.

M R Ehrenstein1, S E Conroy, J Heath, D S Latchman, D A Isenberg.   

Abstract

This study examines the occurrence, nature and distribution of disease flares in systemic lupus erythematosus (SLE) according to organ involvement. One-hundred-and-fourteen patients were seen in the Lupus Clinic of the Bloomsbury Rheumatology Unit over a 3-yr period. At each visit a data sheet was completed to assess their disease activity in eight separate organs/systems according to the British Isles Lupus Assessment Group (BILAG) activity index. This information was entered into a computer and a score for each organ system was obtained. The record of each individual patient was examined to identify flares in the individual organs; 458 flares occurred in 107 patients. The majority of patients (69%) experienced more than one flare during the study period. Fifty-four per cent of patients had flares in more than one system simultaneously, but the majority (70%) of flares involved only one system. The most severe organ involvement (A score) was most commonly observed in the musculoskeletal system, whereas severe renal disease occurred only three times. These results indicate that although SLE is a multisystem disease, the flares that occur tend to be confined to one system at a time. Further, these results demonstrate that in our rheumatology practice the most common 'A' flare observed was severe polyarthritis (A score in musculoskeletal).

Entities:  

Mesh:

Year:  1995        PMID: 7728402     DOI: 10.1093/rheumatology/34.3.257

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  5 in total

1.  Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy.

Authors:  Fei Gu; Dandan Wang; Huayong Zhang; Xuebing Feng; Gary S Gilkeson; Songtao Shi; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2014-08-14       Impact factor: 2.980

2.  Major flares in women with SLE on combined oral contraception.

Authors:  D A Whitelaw; S J Jessop
Journal:  Clin Rheumatol       Date:  2007-05-09       Impact factor: 2.980

3.  Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.

Authors:  Joan T Merrill; C Michael Neuwelt; Daniel J Wallace; Joseph C Shanahan; Kevin M Latinis; James C Oates; Tammy O Utset; Caroline Gordon; David A Isenberg; Hsin-Ju Hsieh; David Zhang; Paul G Brunetta
Journal:  Arthritis Rheum       Date:  2010-01

4.  Covariate association eliminating weights: a unified weighting framework for causal effect estimation.

Authors:  Sean Yiu; Li Su
Journal:  Biometrika       Date:  2018-09-03       Impact factor: 2.445

Review 5.  Lupus Cohorts.

Authors:  Christopher Redmond; Omer Pamuk; Sarfaraz A Hasni
Journal:  Rheum Dis Clin North Am       Date:  2021-06-10       Impact factor: 2.032

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.